Licensing Opportunities available from Warwick Innovations
 |
 |
 |
 |
 |
 |
| Biology | Chemistry | Computing | Engineering | Medicine | Physics |
These pages contain details of the technologies currently available to licence from Warwick Innovations.
If you would like more details of any of these technologies, please contact the relevant Business Development
Manager.
New technologies are added regularly, so do please register your interest and we will send through details of
opportunities as they are published. You can also use the RSS feed on the Licensing Opportunities page to
keep up to date.
Rapid diagnostic test for SARS-CoV-2
Coronavirus diagnostics currently require centralised facilities and collection/distribution of swabs and results are ‘next day’. A new diagnostic tool being developed by the University of Warwick and its partner Iceni Diagnostics may allow on-the-spot detection of Coronavirus infection, without facilities using a simple disposable device.
More details: Rapid diagnostic test for SARS-CoV-2
Contact: Dr James Lapworth, Warwick Innovations email: j.lapworth@warwick.ac.uk
Non-invasive, ECG based low-level glucose detection
Tracking sugar in the blood is crucial for both healthy individuals and diabetic patients. The University of Warwick has developed an algorithm that continuously detects low glucose levels using an ECG device.
More details: Non-invasive, ECG based low-level glucose detection
The paper was published in Nature, 13 January 2020.
Contact: Dr Shum Prakash, Business Development Manager, Warwick Ventures. Tel: +44 (0) 24 7657 4145; email:s.prakash@warwick.ac.uk
Real-time Video Analysis
Each day in 2019, around 2,000 petabytes of video data are generated by security cameras around the world. This is equivalent to 75 million users streaming an hour’s HDTV simultaneously. Analysing this data is increasingly difficult, but new video analytics from the University of Warwick can outperform other methods, whilst requiring less processing and training time, and less storage.
More details: Real-time Video Analysis
Contact: Dr Shum Prakash, Business Development Manager, Warwick Ventures. Tel: +44 (0) 24 7657 4145; email:s.prakash@warwick.ac.uk
A Novel Ammonia Synthesis Catalyst Promoter for the Haber-Bosch Process
A University of Warwick team, led by Professor Shanwen Tao, has available for license intellectual property, a novel catalyst promoter for improving the efficiency of ammonia synthesis using the Haber-Bosch process.
More details: A Novel Ammonia Synthesis Catalyst - Licensing Opportunity
Contact: Dr James Lapworth, Business Development Manager, Warwick Innovations. Tel: +44 (0) 2476 575 481 email:j.lapworth@warwick.ac.uk
Improvements to electrospray ionisation
A University of Warwick team, led by Professor Pete O’Connor, has available for licence intellectual property using CI to increase the average charge state of ions generated by electrospray ionisation.
More details: Improvements to eletrospray ionisation
Contact: Dr Shum Prakash, Business Development Manager, Warwick Ventures. Tel: +44 (0) 24 7657 4145; email:s.prakash@warwick.ac.uk
IVF pre-implantation screening method
A team at the University of Warwick has developed a new screening test that potentially provides an accurate and noninvasive method for assessing embryos during IVF treatment, prior to implantation.
More details: IVF pre-implantation screening method
Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: 
+44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk
Increased Epigenetic Variation in Plants
A team at the University of Warwick has developed technology to increase the epigenetic variety of plants without the usual undesired side effects. The novel strategy allows a much greater range of epigenetic and phenotypic differences to be introduced than was previously possible.
More details: Increased epigenetic variation in plants
Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk
New Test to Accurately Determine the Onset of Labour
A team at the University of Warwick has developed a new test that provides an accurate way to confirm the onset of labour in both full term and preterm pregnancies. A second application for the test is expected to be the identification of women who may not progress during induction.
More details: A new test to accurately determine the onset of labour
Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk
A novel target and therapeutic leads for the treatment of bovine and human RSV
Warwick Ventures has available for licence a patent application covering an entirely novel conserved host cell protein target for the treatment of bovine and human RSV. Promising proof-of-concept studies have demonstrated significant anti-viral activity with a number of chemical lead compounds which are suitable for entry into a drug discovery program.
More details: A novel target and therapeutic leads for the treatment of bovine and human RSV
Contact: Andrew Lee, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75745; email: L.Lane@warwick.ac.uk
Novel Cryopreservation Technique
Warwick Ventures has available for licence a novel cryopreservation technique, without the need for vitrification, resulting in enhanced cell preservation and reduction of cell damage. This technology has many applications, but is particularly suited to the preservation of cell lines or blood for transfusion. This technology would be of interest to companies involved in sample handling and storage, or organisations involved in the collection and storage of cellular materials.
More details: Novel Cryopreservation Technique
Contact: Laura Lane, Business Development Associate, Warwick Ventures. Tel: (0)24 765 75745
Email: l.lane@warwick.ac.uk